Concepedia

Carrie L Kass

CL

Statistics

Publications

4

Citations

84

H-Index

4

Active since

2000

Affiliations

University of Colorado Denver(Current)

Carrie L Kass is an author at University of Colorado Denver specializing in medicine, cancer therapeutics, and cancer research.

Top concepts

Publications per year

2000–2011

4

Publications

4

Abstract B243: A phase I dose-escalation study of MEK inhibitor MEK162 (ARRY-438162) in patients with advanced solid tumors.

Johanna C. Bendell, Kyriakos P. Papadopoulos, Suzanne F. Jones et al. · Molecular Cancer Therapeutics · 2011 · 28 citations

, , +15

Fludrocortisone for the Treatment of Heparin-Induced Hyperkalemia

Deb Sherman, Carrie L Kass, Douglas N. Fish · Annals of Pharmacotherapy · 2000 · 28 citations

Abstract A143: ARRY-380, a selective HER2 inhibitor: From drug design to clinical evaluation.

Stacy L. Moulder, Tara Baetz, Virginia F. Borges et al. · Molecular Cancer Therapeutics · 2011 · 18 citations

Treatment with histamine dihydrochloride and interleukin-2 in patients with advanced metastatic malignant melanoma

Steven O’Day, Sanjiv S. Agarwala, Peter Naredi et al. · Melanoma Research · 2003 · 10 citations

, , +17

1–4 of 4